Monday, April 10, 2023 12:05:51 PM
iclight,
Nobody is hyping NYAS and ASCO as catalysts for the stock. These events are being promoted because they are important world-renowned conferences in the medical community.
The value of this cell-based immunotherapy platform technology will be determined by the integrity of the science, and the regulatory process will be the catalyst.
Medical conferences are significant. Merck and Pfizer are sponsors of the NYAS event coming up in a few weeks and the conference will be an excellent source to learn about the latest breakthroughs in the field of cancer immunotherapy. PD1 combo will probably be one of the most notable highlights this year!
NYAS 2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171539116
ASCO 2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171648758
Nobody is hyping NYAS and ASCO as catalysts for the stock. These events are being promoted because they are important world-renowned conferences in the medical community.
The value of this cell-based immunotherapy platform technology will be determined by the integrity of the science, and the regulatory process will be the catalyst.
Medical conferences are significant. Merck and Pfizer are sponsors of the NYAS event coming up in a few weeks and the conference will be an excellent source to learn about the latest breakthroughs in the field of cancer immunotherapy. PD1 combo will probably be one of the most notable highlights this year!
NYAS 2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171539116
ASCO 2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171648758
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
